Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recognition Mechanism of the "Sara-sara Feel" of Cosmetic Powders.
Kato Y, Kuhara R, Sakamoto M, Tsuchiya R, Nagatani N, Nonomura Y. Kato Y, et al. Among authors: nagatani n. J Oleo Sci. 2021 Feb 1;70(2):195-202. doi: 10.5650/jos.ess20252. Epub 2021 Jan 15. J Oleo Sci. 2021. PMID: 33456008 Free article.
Physical origin of a complicated tactile sensation: 'shittori feel'.
Kikegawa K, Kuhara R, Kwon J, Sakamoto M, Tsuchiya R, Nagatani N, Nonomura Y. Kikegawa K, et al. Among authors: nagatani n. R Soc Open Sci. 2019 Jul 10;6(7):190039. doi: 10.1098/rsos.190039. eCollection 2019 Jul. R Soc Open Sci. 2019. PMID: 31417711 Free PMC article.
Treatment of Retinoblastoma 1-Intact Hepatocellular Carcinoma With Cyclin-Dependent Kinase 4/6 Inhibitor Combination Therapy.
Sheng J, Kohno S, Okada N, Okahashi N, Teranishi K, Matsuda F, Shimizu H, Linn P, Nagatani N, Yamamura M, Harada K, Horike SI, Inoue H, Yano S, Kumar S, Kitajima S, Ajioka I, Takahashi C. Sheng J, et al. Among authors: nagatani n. Hepatology. 2021 Oct;74(4):1971-1993. doi: 10.1002/hep.31872. Epub 2021 Aug 25. Hepatology. 2021. PMID: 33931882
Retinoblastoma Inactivation Induces a Protumoral Microenvironment via Enhanced CCL2 Secretion.
Li F, Kitajima S, Kohno S, Yoshida A, Tange S, Sasaki S, Okada N, Nishimoto Y, Muranaka H, Nagatani N, Suzuki M, Masuda S, Thai TC, Nishiuchi T, Tanaka T, Barbie DA, Mukaida N, Takahashi C. Li F, et al. Among authors: nagatani n. Cancer Res. 2019 Aug 1;79(15):3903-3915. doi: 10.1158/0008-5472.CAN-18-3604. Epub 2019 Jun 12. Cancer Res. 2019. PMID: 31189648
The RB-IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity.
Kitajima S, Yoshida A, Kohno S, Li F, Suzuki S, Nagatani N, Nishimoto Y, Sasaki N, Muranaka H, Wan Y, Thai TC, Okahashi N, Matsuda F, Shimizu H, Nishiuchi T, Suzuki Y, Tominaga K, Gotoh N, Suzuki M, Ewen ME, Barbie DA, Hirose O, Tanaka T, Takahashi C. Kitajima S, et al. Among authors: nagatani n. Oncogene. 2017 Sep 7;36(36):5145-5157. doi: 10.1038/onc.2017.124. Epub 2017 May 8. Oncogene. 2017. PMID: 28481867
MicroRNA-140 mediates RB tumor suppressor function to control stem cell-like activity through interleukin-6.
Yoshida A, Kitajima S, Li F, Cheng C, Takegami Y, Kohno S, Wan YS, Hayashi N, Muranaka H, Nishimoto Y, Nagatani N, Nishiuchi T, Thai TC, Suzuki S, Nakao S, Tanaka T, Hirose O, Barbie DA, Takahashi C. Yoshida A, et al. Among authors: nagatani n. Oncotarget. 2017 Feb 21;8(8):13872-13885. doi: 10.18632/oncotarget.14681. Oncotarget. 2017. PMID: 28099924 Free PMC article.
35 results